Health · 1 views
Egyptian group developing Ebola vaccine
Minapharm will receive up to $16.5 million from the Coalition for Epidemic Preparedness Innovations (CEPI) to work on a vaccine to combat the Bundibugyo species of Ebola, the companies said in a joint statement.
Source AI Summary Updated 37m ago
Health 
Story intelligence Beta
Confidence Limited Single-outlet story
Views 1 Community interest
Brief read ~25 words
AI Summary
An Egyptian pharmaceutical firm announced on Thursday that it is developing a potential vaccine targeting the Ebola strain currently affecting the Democratic Republic of Congo.
Read full article on Medical XpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Pennsylvania records first 2 measles deaths in 35 yearsContinue reading
- AI can detect heart disease in women using mammograms, study suggestsContinue reading
- Earlier menopause linked to higher risk of bronchiectasisContinue reading
- RFK Jr. said a Samoa trip had nothing to do with vaccines. New documents refute thatContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow